A. Malankar

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

H. Hochster, F. Muggia, P. Ivy, 2013, Cancer Chemotherapy and Pharmacology.

A Phase II Trial of Chloroquine in Combination with Bortezomib and Cyclophosphamide in Patients with Relapsed and Refractory Multiple Myeloma

A. Mazumder, S. Marcus, A. Saran, 2014 .

Ligand-inducible, prostate stem cell antigen (PSCA)-directed GoCAR-T cells in advanced solid tumors: Preliminary results from a dose escalation.

O. Gardner, C. Becerra, A. Foster, 2019, Journal of Clinical Oncology.

Ligand-inducible, prostate stem cell antigen (PSCA)-directed GoCAR-T™ cells in advanced solid tumors: Preliminary results from a dose escalation study

O. Gardner, C. Becerra, G. Manji, 2018, Annals of Oncology.